Your search for

63 results were returned

  1. Twobirds news
    05 February 2020
    Bird & Bird advises Arm pro bono on flagship healthcare project to test a device aimed to solve the digital needs of remote healthcare workers
    www.twobirds.com/en/news/press-releases/2020/united-kingdom/bird-and-bird-advises-arm-pro-bono-on-flagship-healthcare

    International law firm Bird & Bird advises international semiconductor design company, Arm, pro bono on a 15-month project in partnership with Be Healthy Be Mobile (a joint initiative between the World Health ...

  2. Legal news
    16 May 2019
    Report from Med-Tech Innovation Expo 2019
    www.twobirds.com/en/news/articles/2019/uk/bird-and-birds-ewan-grist-chris-de-mauny-and-toby-bond-spoke-at-the-med-tech-innovation-expo

    Ewan explored the legal issues which arise at various stages of the lifecycle of a medical device; from product concept, though prototyping, testing, refinement, manufacture, marketing and placing on the market.

  3. Legal news
    02 July 2018
    Arrow still flies
    www.twobirds.com/en/news/articles/2018/uk/arrow-still-flies

    During 2016 and 2017 the complex litigation about part of AbbVie's patent portfolio protecting its Humira/adalimumab product drew attention in part because of the granting of a so-called Arrow declaration.

  4. Legal news
    14 September 2018
    Patents: interpretation of Supplementary Protection Certificate Regulation
    www.twobirds.com/en/news/articles/2018/uk/patents-interpretation-of-supplementary-protection-certificate-regulation

    The European Court of Justice (ECJ) has ruled that a product composed of several active ingredients with a combined effect may be protected by a basic patent in force under the Supplementary Protection Certificate (SPC) ...

  5. Legal news
    22 December 2020
    High Court considers requirements for an exclusive patent licence (Neurim v Mylan)
    www.twobirds.com/en/news/articles/2020/uk/high-court-considers-requirements-for-an-exclusive-patent-licence

    In the LexisNexis case analysis, Senior IP Associate, Will Smith, talks about the decision in the following matter: Neurim Pharmaceuticals (1991) Ltd & Anor v Generics UK Ltd (t\a MYLAN) [2020] EWHC 3270 (Pat). This ...

  6. Legal news
    21 January 2020
    Transfers of value to “influencers”: new disclosure obligation for companies in the health sector
    www.twobirds.com/en/news/articles/2020/uk/transfers-of-value-to-influencers-new-disclosure-obligation-for-companies-in-the-health-sector

    The list of beneficiaries of transfers of value subject to compulsory disclosure in the French public “transparency” database include “persons who, in the media or on social media, present one or several health ...

  7. Legal news
    24 June 2020
    UK Supreme Court upholds Kymab's appeal imposing a stricter interpretation of sufficiency of disclosure for patents
    www.twobirds.com/en/news/articles/2020/uk/uk-supreme-court-upholds-kymabs-appeal

    In a judgment handed down today the UK Supreme Court has upheld the appeal of Kymab who had challenged Regeneron's patents covering Kymab's 'Kymouse' transgenic mouse.

  8. Twobirds news
    30 May 2019
    International team advises Chiesi Farmaceutici on in-licence of Raxone® from Santhera
    www.twobirds.com/en/news/press-releases/2019/uk/international-team-advises-chiesi-farmaceutici-on-inlicence-of-raxone-from-santhera

    International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")

  9. Twobirds news
    20 May 2020
    English High Court decides that Merck Sharp & Dohme Corp should be injuncted from using "Merck" alone in the UK
    www.twobirds.com/en/news/press-releases/2020/united-kingdom/english-high-court-decides-that-merck-sharp-and-dohme-corp-should-be-injuncted-from-using-merck

    The English High Court today handed down its decision in the proceedings brought by Merck KGaA, Darmstadt, Germany (the "Claimant") against Merck Sharp & Dohme Corp and others ("MSD") for breach of contract and trade ...

  10. Legal news
    08 May 2019
    Patents: obviousness in relation to patent for dosage regime
    www.twobirds.com/en/news/articles/2019/global/patents-obviousness-in-relation-to-patent-for-dosage-regime

    The Supreme Court has confirmed that a patent for a dosage regime of a drug used to treat erectile dysfunction (ED) was obvious over the prior art.